Fresenius SE & Co. KGaA (FRA:FRE – Get Rating) has been given a €51.00 ($53.68) price objective by research analysts at Warburg Research in a note issued to investors on Tuesday, Borsen Zeitung reports. Warburg Research’s price objective suggests a potential upside of 49.87% from the company’s current price.
Other equities research analysts have also recently issued research reports about the company. Berenberg Bank set a €60.25 ($63.42) price objective on Fresenius SE & Co. KGaA in a report on Friday, April 29th. Sanford C. Bernstein set a €40.00 ($42.11) price objective on Fresenius SE & Co. KGaA in a report on Thursday, March 3rd. Deutsche Bank Rese… set a €36.00 ($37.89) price objective on Fresenius SE & Co. KGaA in a report on Thursday, May 5th. The Goldman Sachs Group set a €49.00 ($51.58) price objective on Fresenius SE & Co. KGaA in a report on Friday, April 1st. Finally, Deutsche Bank Aktiengesellschaft set a €36.00 ($37.89) price objective on Fresenius SE & Co. KGaA in a report on Tuesday, March 1st. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and an average target price of €43.40 ($45.69).
Shares of FRE stock traded down €1.02 ($1.07) during mid-day trading on Tuesday, hitting €34.03 ($35.82). 1,509,405 shares of the company’s stock were exchanged. Fresenius SE & Co. KGaA has a fifty-two week low of €60.16 ($63.33) and a fifty-two week high of €80.00 ($84.21). The stock has a 50-day simple moving average of €32.69 and a two-hundred day simple moving average of €35.16.
Fresenius SE & Co KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Featured Articles
- If PetMeds Is A Good Buy There Will Be A Better Signal
- Insiders Buy Occidental Petroleum Ahead Of Q1 Earnings
- High-Yield Deep-Value LCI Industries Exceeds All Expectations
- Shopify (NYSE: SHOP) Approaches Key Support Level
- The Low In Lordstown Motors May Not Be The Last
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
